Table 2. Growth, inflammation, and morbidity as correlates of baseline SC (pmol/L) in 1,192 children with MAM1.
| Unadjusted | Age–sex adjusted | ||||
|---|---|---|---|---|---|
| n | B (95% CI) | p | B (95% CI) | p | |
| Sex | |||||
| Female | 645 | - | |||
| Male | 547 | −8 (−22; 6) | 0.27 | −11 (−25; 2) | 0.10 |
| Age (month) | |||||
| 6 to 11 | 629 | - | - | ||
| 12 to 18 | 339 | 26 (11; 42) | 0.001 | 28 (12; 44) | 0.001 |
| 18 to 24 | 224 | 52 (34; 70) | <0.001 | 53 (35; 71) | <0.001 |
| Anthropometry | |||||
| MUAC (mm) | |||||
| >125 | 234 | - | |||
| ≤125 | 958 | 3 (−15; 20) | 0.75 | 4 (−14; 22) | 0.65 |
| WLZ | |||||
| >−2 | 351 | - | |||
| ≤−2 | 841 | 8 (−7; 23) | 0.29 | 5 (−11; 20) | 0.55 |
| LAZ | |||||
| >−2 | 736 | - | |||
| >−3 and ≤−2 | 334 | 10 (−6; 25) | 0.23 | 1 (−14; 17) | 0.85 |
| ≤−3 | 122 | −10 (−33; 13) | 0.40 | −23 (−46; 1) | 0.06 |
| Inflammation and morbidity | |||||
| Serum CRP (mg/L) | |||||
| ≤2 | 569 | - | |||
| >2 and ≤10 | 341 | 6 (−10; 22) | 0.46 | 2 (−14; 18) | 0.78 |
| >10 | 282 | −6 (−24; 11) | 0.47 | −9 (−26; 8) | 0.31 |
| Serum AGP (g/l) | |||||
| ≤0.8 | 241 | - | - | ||
| >0.8 and ≤1.2 | 366 | 11 (−8; 31) | 0.26 | 7 (−12; 27) | 0.45 |
| >1.2 | 585 | 15 (−4; 33) | 0.11 | 7 (−11; 25) | 0.46 |
| Ill last 2 weeks | |||||
| No | 739 | - | - | ||
| Yes | 445 | −6 (−20; 9) | 0.43 | −8 (−22; 6) | 0.25 |
| Malaria (Rapid test) | |||||
| Negative | 726 | - | - | ||
| Positive | 463 | −16 (−30; −2) | 0.03 | −21 (−35; −6) | 0.004 |
1Data shown as number (n), regression coefficient B (95% CI), and p-value. Numbers in categories may not add up, due to missing values.
AGP, α1-acid glycoprotein; CRP, C-reactive protein; LAZ, length-for-age z-score; MAM, moderate acute malnutrition; MUAC, mid-upper arm circumference; SC, serum cobalamin; WLZ, weight-for-length z-score.